Lead sponsor
Methodist Health System
1 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 6, 2026.
1
Trials led
0
Ongoing
0
Total enrollment
0
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Trials by status
Withdrawn
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment StrategyBMI ≥30Ph 1Withdrawnnot disclosed